These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 9724862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [Abstract] [Full Text] [Related]

  • 4. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M, Marne RB, Varikkodan R, Bala N, Dandakeri S, Martis J.
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Status of the multibacillary leprosy patients treated with combined regimens of 1 year duration, after a mean follow-up of more than 5 years.
    Pattyn SR, Bourland J, Deverchin J, Ghys P, Grillone S, Groenen G, Janssens L, Kuykens P.
    Lepr Rev; 1991 Sep; 62(3):337-9. PubMed ID: 1795593
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
    Sales AM, Sabroza PC, da Costa Nery JA, Duppre NC, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):320-3. PubMed ID: 15485290
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elimination of leprosy from India--prospects & challenges.
    Noordeen SK.
    Indian J Public Health; 2003 Sep; 47(4):183-7. PubMed ID: 15125560
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Duration of MDT for paucibacillary leprosy.
    Ramu G.
    Indian J Lepr; 1992 Sep; 64(1):1-7. PubMed ID: 1290484
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A study on non-adherence to MDT among leprosy patients.
    Rao PS.
    Indian J Lepr; 2008 Sep; 80(2):149-54. PubMed ID: 19425509
    [Abstract] [Full Text] [Related]

  • 20. Multidrug therapeutic challenges in leprosy.
    Jain S, Sehgal VN.
    Int J Dermatol; 1997 Jul; 36(7):493-6. PubMed ID: 9268743
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.